Do Ovulation Tests Work With PCOS (Now PMOS)? What the Strip Can and Can't Tell You

You bought the box of thirty strips because it seemed like the sensible, low-drama way to answer one question. Then day four was positive. So was day five. By day nine you were holding a strip up to the window, comparing it against yesterday's on the bathroom shelf, and quietly deciding you must be doing it wrong.

You are almost certainly not doing it wrong. Ovulation predictor kits are built on an assumption about your cycle that PCOS — now PMOS, after the 2026 Lancet consensus renamed it Polyendocrine Metabolic Ovarian Syndrome — frequently breaks. The strips are not defective. They are being asked a question they were not designed to answer.

The honest version is more useful than either the "they don't work, don't bother" answer or the "buy this monitor instead" answer. Here is what a urine LH test can genuinely tell you, what it cannot, and what the guideline says to measure when you actually need to know.

What the strip is measuring, and the assumption underneath it

A standard ovulation test detects luteinising hormone (LH) in urine. In a textbook cycle, LH sits low for two weeks, spikes sharply for a day or so, and that spike triggers the ovary to release an egg roughly a day to a day and a half later. The strip is a threshold detector. It is not measuring how much LH you have; it is checking whether you have crossed a line that, in a textbook cycle, only the surge crosses.

That design works because it assumes your baseline sits well below the line. In PMOS, that assumption often fails.

Why the test reads positive when nothing is happening

The mechanism is upstream of the ovary. A 2022 review of the neuroendocrine drivers of PCOS describes a persistent rapid GnRH pulse frequency in women with the condition, present across the whole ovulatory cycle — the pituitary is being told to release LH faster and more often, all month, not just at mid-cycle.

The downstream consequence is a raised LH baseline. If your everyday LH already sits near the strip's threshold, two things follow. Ordinary fluctuation pushes you over the line on days when nothing is happening, which reads as a positive. And a real surge, when it comes, has less distance to travel above the noise, so it does not stand out as the unmistakable event the instructions describe.

This is worth saying plainly: a positive strip in PMOS can mean a surge, or it can mean your normal Tuesday. The test cannot distinguish between them, because it was never built to.

We have not found a reliable figure for how often this happens, and we would be sceptical of anyone who quotes you one. What is well established is the direction of the problem, not its prevalence.

The second failure, and it is the quieter one

Everyone talks about false positives. The other failure gets less attention and probably wastes more cycles.

Strips tell you when, which only helps if you already know roughly when to start looking. Testing protocols assume a cycle length you can predict within a few days. If your cycles run 45 days, or 60, or arrive without a pattern, there is no sensible day to begin — so you either test for weeks and run out of strips before anything happens, or you start too late and miss it entirely.

A month of negatives, in that situation, is not evidence that you did not ovulate. It is evidence that you were not testing on the right days. Those are very different conclusions, and treating the first as the second is how people end up believing they never ovulate at all.

A surge is a prediction. It is not proof.

This is the distinction that matters most, and it is true for everyone — it simply matters more here.

LH rises before ovulation. It is a forecast. Whether the follicle actually released an egg is a separate question, answered afterwards by progesterone, which only rises once the corpus luteum forms. So even a clean, unambiguous positive strip tells you an attempt was signalled. It does not tell you the attempt succeeded.

The 2023 International Evidence-based Guideline is direct about how to settle it: "Ovulatory dysfunction can still occur with regular cycles, and if anovulation needs to be confirmed, serum progesterone levels can be measured." That is the recommended route — a timed blood test, roughly a week before your period is due.

Two things about that sentence are worth noticing. It says regular bleeding does not guarantee ovulation, which is the same trap as watching the calendar and feeling reassured — we cover the bleeding-versus-ovulating gap in more detail in how long is too long to go without a period. And the guideline does not mention urine LH tests anywhere. It does not argue against them. It simply does not treat them as an instrument for confirming ovulation, which is roughly the position the evidence supports.

There is also a layer beneath "did it happen." A small pilot study of a four-hormone home monitoring kit — 40 women, run by the manufacturer, so read it as a signal rather than a settled finding — detected a progesterone-metabolite rise in 38 participants, but only 22 sustained that level through the window when an embryo would implant. Ovulation occurring and the luteal phase being adequate are not the same question. If you are tracking for fertility rather than curiosity, that is the more demanding one.

The other tools, and what each can honestly tell you

We sell none of these, which makes it easier to be blunt about them.

Basal body temperature. Detects the small sustained rise that follows ovulation, so it confirms rather than predicts, and only in hindsight. It is cheap and genuinely informative over several months. It is also easily disrupted by broken sleep, alcohol, illness and a slightly late alarm — the exact conditions of an ordinary life.

Calendar and app predictions. These extrapolate from your previous cycle lengths. With irregular cycles there is nothing stable to extrapolate from, so treat the fertile window they draw as decoration.

Multi-hormone urine monitors. Adding oestrogen and a progesterone metabolite addresses the real gap, because it moves from predicting to confirming. They cost considerably more than strips, the independent evidence base in PMOS specifically is thin, and much of the published work comes from the companies selling them. Not a reason to dismiss them — a reason to buy one with clear eyes.

Ultrasound follicle tracking and serum progesterone. The clinical options, and the ones that actually resolve the question. Both need a doctor.

What to do with the box you already own

Keep using it, if you want to — but change what you expect from it. Log the results rather than reacting to them, and treat a positive as possibly worth attention instead of a starting gun. A run of consecutive positives is itself information: it suggests a raised baseline, which is a reasonable thing to bring to an appointment.

The more valuable move is to stop trying to settle this in the bathroom. If you have been testing for two or three cycles without a clear answer, or if you are trying to conceive, the specific ask is a timed serum progesterone about seven days before your period is expected — and if your cycles are too irregular to time it, say exactly that, because the answer is usually a different monitoring plan rather than a different strip. If you have had bloodwork already, what each number on a PCOS panel means may explain more of it than you were told at the time.

Ovulation is one part of the picture, and it is driven by different things in different people — insulin resistance, androgens, thyroid, cortisol, cycle disruption. Our free assessment takes no bloodwork and does not diagnose anything; it reads which of those drivers your symptom pattern points at, which is often the thing that decides whether tracking is even the right next step.

Nothing here replaces a conversation with your own doctor. But you can walk into it knowing which test answers which question, which is more than the box of strips told you.

Sources

• Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE. "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." The Journal of Clinical Endocrinology and Metabolism 2023 Sep 18;108(10):2447–2469. PMID 37580314. (Section 1.1.5: ovulatory dysfunction can occur with regular cycles, and serum progesterone can be measured to confirm anovulation. The guideline does not address urinary LH tests.)
• Szeliga A, Rudnicka E, Maciejewska-Jeske M, Kucharski M, Kostrzak A, Hajbos M, Niwczyk O, Smolarczyk R. "Neuroendocrine Determinants of Polycystic Ovary Syndrome." International Journal of Environmental Research and Public Health 2022 Mar 6;19(5):3089. PMID 35270780. (Review; describes persistent rapid GnRH pulse frequency across the whole ovulatory cycle in PCOS.)
• Wegrzynowicz AK, Beckley A, Eyvazzadeh A, Levy G, Park J, Klein J. "Complete Cycle Mapping Using a Quantitative At-Home Hormone Monitoring System in Prediction of Fertile Days, Confirmation of Ovulation, and Screening for Ovulation Issues Preventing Conception." Medicina (Kaunas) 2022 Dec 15;58(12):1853. PMID 36557055. (Pilot, n=40, authors affiliated with the manufacturer: progesterone-metabolite rise detected in 38 of 40 cycles, but only 22 sustained a level above threshold through the implantation window.)
• The timing of the LH surge relative to ovulation, and the post-ovulatory rise in progesterone, are well-established general reproductive physiology rather than findings from a single study.